Abstract
Introduction
Lumbar fusion remains a cornerstone for managing degenerative lumbar disorders. Recently, Unilateral Biportal Endoscopic Lumbar Interbody Fusion (ULIF) has emerged as a key minimally invasive technique with promising clinical outcomes. This narrative review analyzes current applications, technical advancements, and the existing evidence base for ULIF. It also highlights the challenges, controversies, and research gaps that may affect its widespread adoption, offering insights to guide future clinical practice.
Methods
A structured literature search of the PubMed, Web of Science, Embase, and Cochrane Library databases was conducted for relevant articles published through August 2025. Search terms included “unilateral biportal endoscopic,” “UBE,” “biportal endoscopic spine surgery,” “lumbar interbody fusion,” “ULIF,” and “BE–TLIF.” This review critically synthesizes findings from clinical studies, technical reports, and systematic reviews focusing on surgical techniques, clinical efficacy, fusion outcomes, and complications associated with ULIF.
Results
ULIF is increasingly utilized for a wide spectrum of lumbar degenerative diseases. Comparative studies indicate that while ULIF yields comparable long-term fusion rates and clinical improvements to minimally invasive transforaminal lumbar interbody fusion (MIS–TLIF), it offers distinct advantages, such as reduced intraoperative blood loss and shorter hospital stays. However, these benefits are often offset by longer operative times, particularly during the initial learning curve. Technical innovations, including novel cage designs and navigation systems, aim to enhance fusion and restore sagittal alignment. Despite its potential, the technique's adoption is challenged by this steep learning curve and a distinct complication profile, including concerns regarding dural tears, epidural hematomas, and nerve root injuries. Questions also remain regarding its cost-effectiveness and its ability to achieve superior radiological outcomes.
Conclusions
ULIF represents a safe and effective minimally invasive alternative for treating various lumbar spine disorders. However, its widespread adoption is constrained by its technical demands, a specific complication profile, and unresolved questions regarding its cost-effectiveness and long-term radiological benefits. Future high-quality research, particularly multicenter Randomized Controlled Trials (RCTs), is necessary to definitively establish its long-term efficacy, standardize surgical techniques, and optimize patient safety.
Keywords: Lumbar degenerative disease, Lumbar interbody fusion, Spinal endoscopy, Unilateral biportal endoscopic technique, Minimally invasive spine surgery
Introduction
The incidence of lumbar degenerative diseases, such as lumbar disc herniation, spinal stenosis, and spondylolisthesis, is steadily increasing amidst an aging global population, posing a primary challenge in spinal surgery [1]. Lumbar fusion remains a definitive treatment for these conditions when conservative management fails, especially in the presence of spinal instability. Posterior Lumbar Interbody Fusion (PLIF) remains one of the most widely performed traditional open procedures, providing reliable decompression and stabilization [2]. However, this approach is associated with considerable iatrogenic injury to the paraspinal muscles, which may result in complications, such as chronic postoperative back pain and adjacent segment disease [3–5].
To address these limitations, minimally invasive surgery (MIS) techniques emerged. Minimally invasive transforaminal lumbar interbody fusion (MIS–TLIF), performed through a tubular retractor, established itself as a standard of care, mitigating soft tissue injury compared to open approaches [6, 7]. More recently, the Unilateral Biportal Endoscopic (UBE) technique has gained prominence. Consequently, its application in lumbar fusion, known as Unilateral Biportal Endoscopic Lumbar Interbody Fusion (ULIF), is rapidly expanding [8].
The emergence of ULIF marks a significant evolution from 'endoscope-assisted' to 'fully endoscopic' spinal fusion. Unlike previous techniques where endoscopes were used primarily for visualization aids, ULIF enables the entire fusion procedure—including neural decompression, endplate preparation, bone grafting, and interbody cage insertion—to be performed under direct, magnified endoscopic vision [9, 10]. The UBE technique is characterized by its use of two independent portals—one for viewing and another for working. This setup, analogous to arthroscopy, enables triangulation of instruments, affording surgical dexterity and freedom of movement often difficult to achieve with single-portal endoscopy [11–13]. Furthermore, the continuous saline irrigation system maintains a clear surgical field, minimizes thermal injury from drills or radiofrequency devices, and mitigates the risk of infection [14]. This combination permits a complex procedure like spinal fusion to be performed through minimal incisions, minimizing iatrogenic injury while enhancing surgical precision.
Comparative studies suggest that ULIF achieves fusion rates and long-term clinical outcomes comparable to MIS–TLIF, supporting its efficacy [15, 16]. Currently, the primary ULIF approaches include biportal endoscopic transforaminal lumbar interbody fusion (BE–TLIF) and biportal endoscopic extraforaminal lumbar interbody fusion (BE–EFLIF) [17, 18]. This narrative review summarizes the current evidence on ULIF, with an emphasis on its technical developments, clinical applications, and the ongoing challenges and controversies in modern spine surgery.
Literature search strategy
A structured literature search of the PubMed, Web of Science, Embase, and Cochrane Library databases was conducted for relevant English-language studies published up to August 2025. The search strategy utilized a combination of keywords and MeSH terms: “(unilateral biportal endoscopic OR biportal endoscopic spine surgery OR UBE OR BESS) AND (lumbar interbody fusion OR interbody fusion OR ULIF OR BE–TLIF OR TLIF)”.
The initial database search yielded 2432 records. An additional 25 studies were identified through manual screening of reference lists from retrieved systematic reviews and key articles. After the removal of 254 duplicates, a total of 2203 records were screened based on their titles and abstracts. Of these, 1989 records were excluded, because they were clearly irrelevant (e.g., different surgical techniques, basic science/biomechanical studies, and non-English studies). This left 214 potentially eligible studies for full-text review; however, 33 of these articles could not be obtained. The remaining 181 studies were subjected to a full-text review. An additional 108 studies were excluded based on pre-defined criteria: (1) case reports with fewer than 10 patients; (2) conference abstracts or technical notes without clinical data; or (3) lacking relevant clinical or radiological outcomes for this review.
Ultimately, a total of 73 studies met the inclusion criteria and were included in this narrative review. This selection process is summarized in a PRISMA-style flowchart (Fig. 1). This review prioritized clinical studies, comparative trials, technical reports, and systematic reviews to analyze the efficacy, challenges, and outcomes of ULIF for degenerative lumbar diseases.
Fig. 1.
Flowchart of the literature selection process
A PRISMA-style diagram illustrating the study identification, screening, eligibility, and inclusion process for this narrative review.
The development of UBE technology
The origins of spinal endoscopy date to the early 1980s. In 1983, Forst et al. [19] first performed an arthroscopy-assisted lumbar discectomy. In 1996, Kambin et al. [20] applied arthroscopic techniques to lateral recess stenosis, and in the same year, De Antoni et al. [21] first described the posterior translaminar approach using UBE technology.
UBE research then remained relatively scarce amidst advancements in other endoscopic techniques until Soliman et al. [22] refined the technique in 2013. They introduced Irrigation Endoscopic Discectomy (IED), which maintains a clear surgical field in a liquid environment [23]. This innovation sparked renewed interest in UBE. In 2017, Heo et al. [24] were the first to apply the technique to lumbar interbody fusion surgery, reporting favorable clinical results. Its development has since accelerated, expanding the application of UBE globally to encompass various spinal surgeries [25, 26].
The ULIF surgical technique: an overview
The ULIF procedure is typically performed under general or epidural anesthesia with the patient in a prone position. The technique relies on establishing two independent skin incisions (Fig. 2a), which enables triangulation and flexible instrumentation, as illustrated in the axial view (Fig. 3a). The surgical approach is transmuscular, navigating the natural cleavage planes of the paraspinal muscles (e.g., between the multifidus and longissimus muscles) rather than detaching them from the spinous processes [17, 18, 27].
Fig. 2.

Intraoperative photographs and radiographs of the ULIF procedure. a Clinical photograph showing the two independent portals (viewing and working) for the UBE technique. b Intraoperative C-arm fluoroscopy used for precise localization of the target level. c Postoperative lateral radiograph showing the final placement of the interbody cage and percutaneous pedicle screws
Fig. 3.
Surgical technique of ULIF. a Axial (transverse) view demonstrating the biportal technique. The spine endoscope (viewing portal) and the working instrument (working portal) create a triangulated approach to the lamina and articular processes, passing through the paraspinal muscles without a tubular retractor. b Posterolateral (Kambin's triangle) view showing the key anatomical corridor for cage insertion. The safe working zone (highlighted in blue) is bordered by the exiting nerve root, the dural sac, and the vertebral endplate, allowing for the safe insertion of an interbody cage
After precise C-arm fluoroscopic localization of the surgical level (Fig. 2b), the two portals are established. Typically, the viewing portal is established just lateral to the spinous process, through which a 0° or 30° spine endoscope is inserted. The working portal is created more laterally, providing an angled trajectory for instruments (Fig. 3a). Unlike a tubular retractor system, the working channel's integrity is maintained dynamically by the instruments and a soft-tissue cannula, protecting surrounding tissues during instrument exchange.
Under continuous saline irrigation and direct endoscopic visualization, the surgeon proceeds with decompression. For a BE–TLIF, this involves a unilateral laminectomy and partial facetectomy to expose the neural elements. The anatomical corridor for cage placement is Kambin's triangle (Fig. 3b). This safe working zone is anatomically defined as a right-angled triangle, with the exiting nerve root as the hypotenuse, the dural sac/traversing nerve root as the medial border (height), and the superior endplate of the caudal vertebra as the base. Following adequate decompression, the surgeon performs a discectomy, meticulously prepares the endplates, and packs autologous bone graft into the intervertebral space before carefully inserting the interbody fusion cage (Fig. 3b). Percutaneous pedicle screws, placed under fluoroscopic guidance, provide final stabilization, with the final construct confirmed radiographically (Fig. 2c). A drainage tube is typically placed before wound closure.
Clinical applications and comparative evidence
The indications for ULIF mirror those of other posterior minimally invasive fusion techniques, primarily addressing degenerative lumbar pathologies such as lumbar disc herniation (LDH), spinal stenosis, and low-grade spondylolisthesis (Meyerding Grades I–II) for which conservative management has failed [24, 28–30]. Rather than analyzing each pathology separately, this review synthesizes the comparative evidence against established standards of care, such as MIS–TLIF and open PLIF, as the findings across different indications are largely consistent.
A large body of evidence now exists comparing the perioperative metrics and clinical outcomes of these techniques (Table 1). A consistent finding is that ULIF offers tangible benefits in the early postoperative period [31–34]. Multiple meta-analyses and comparative studies report that while ULIF and MIS–TLIF yield comparable long-term improvements in pain and functional outcomes, ULIF patients tend to experience significantly less immediate postoperative back pain, facilitating earlier ambulation and shorter hospital stays [35–37]. This benefit is attributed to less muscle dissection and retraction. Furthermore, the continuous irrigation in ULIF provides effective hemostasis, resulting in significantly lower intraoperative blood loss compared to both MIS–TLIF and open surgery [3, 12].
Table 1.
Comparative perioperative and clinical outcomes among ULIF, MIS–TLIF, and conventional open PLIF
| Outcome metric | ULIF | MIS–TLIF | Open PLIF | Key findings and notes |
|---|---|---|---|---|
| Operative Time | Significantly longer | Intermediate | Generally shorter | ULIF is associated with a longer operative time, a finding consistently reported across studies, largely attributed to its steep learning curve [37] |
| Intraoperative blood loss | Significantly the least | Significantly less than open | Highest | The continuous saline irrigation provides both a clear surgical field and an effective tamponade effect for hemostasis [42] |
| Length of hospital stay | Significantly the shortest | Significantly shorter than open | Longest | Patients undergoing ULIF typically have the shortest hospital stay, attributed to reduced surgical trauma and less early postoperative pain, allowing for faster recovery [12] |
| Early postoperative back pain | Significantly the lowest | Lower than open | Highest | Multiple meta-analyses confirm that ULIF provides superior back pain relief in the early postoperative period compared to both MIS–TLIF and open surgery [11, 43, 44] |
| Surgical trauma | Significantly the lowest | Lower than open | Highest | Postoperative levels of inflammatory markers are significantly lower in the ULIF group than in the Open PLIF group, and generally lower than in the MIS–TLIF group [44, 45] |
| Fusion rate at final follow-up | Comparable | Comparable | Comparable | At final follow-up (≥ 1 year), all three techniques achieve high and comparable fusion rates with no statistically significant differences reported in most large-scale comparisons [29, 30] |
| Overall complication rate | Comparable | Comparable | Slightly higher | Meta-analyses show no significant difference in the overall complication rates between ULIF and MIS–TLIF. Specific risks for ULIF require attention, while open surgery may carry a higher risk of infection [35, 46, 47] |
Data are synthesized from multiple published studies. Direct comparison of absolute values should be interpreted with caution; emphasis should be placed on the consistent trends reported across the literature
However, these advantages come at a cost. The most frequently cited drawback is a significantly longer operative time, especially during the steep learning curve [15, 38]. Despite the technical challenges, the final fusion rates at 1- or 2-year follow-up are statistically comparable across ULIF, MIS–TLIF, and open PLIF, which validates its efficacy as a reliable fusion procedure [30, 35, 39]. ULIF has also been shown to be particularly useful in challenging scenarios, such as revision surgery for recurrent disc herniation, where the endoscopic magnification aids in navigating scarred tissue planes [40, 41].
Recent technical advancements
Ongoing innovation aims to overcome limitations and enhance fusion outcomes. A key challenge in posterior fusion is the restricted corridor for cage insertion, which can limit cage size and increase the risk of subsidence [49]. ULIF's flexible, triangulated access facilitates the insertion of larger footprint cages that rest on the stronger vertebral apophyseal ring [50–52]. A recent study by You et al. [53] demonstrated that using large-footprint cages in BE–TLIF resulted in a significantly lower rate of subsidence. Expandable cage technology is another key development, allowing for insertion in a compact state to minimize neural injury risk, followed by in-situ expansion to restore disc height and lordosis [54].
The integration of intraoperative navigation systems into the ULIF workflow aims to improve precision and safety [55]. Kang et al. [56] described an O-arm navigation-guided UBE–TLIF technique to precisely insert a large Lateral Lumbar Interbody Fusion (LLIF) cage through a posterior approach. This hybrid technique combines endoscopic visualization with real-time navigation, reducing the reliance on fluoroscopy. Collectively, these innovations in cage design, materials, and surgical guidance continue to refine the ULIF procedure, aiming to maximize fusion rates and long-term stability while preserving the benefits of a minimally invasive approach [57].
Challenges, controversies, and barriers to widespread adoption
Despite its promise, endoscopic spine surgery has struggled to achieve widespread adoption for decades, and ULIF is no exception. Its growth is constrained by significant challenges and controversies surrounding its technical demands, safety profile, radiological outcomes, and cost-effectiveness.
The steep learning curve
ULIF is a technically demanding procedure that requires surgeons to master new skills, including endoscopic triangulation, managing a fluid surgical environment, and performing complex bony work through small portals [58]. Studies quantifying this learning curve suggest proficiency is often achieved after approximately 30–40 cases [38, 59]. A robust multicenter study by Park et al. [60] reported that surgeons required an average of 39 cases to achieve a stable and efficient operative time. During this initial learning phase, operative times are significantly longer, and complication rates, particularly the need for reoperation, are demonstrably higher [61]. This steep learning curve is arguably the single greatest barrier to adoption, requiring a substantial institutional and individual commitment to structured training to ensure patient safety [62, 63].
Complications and safety controversies
While generally safe, ULIF is associated with a distinct complication profile (Table 2). A major point of controversy surrounds the rate of nerve root injury and dural tears [64]. Pooled data suggest a dural tear incidence between 1.9% and 5.2%, a rate often reported as comparable to MIS–TLIF [65, 66]. However, critics argue that the risk may be higher in less experienced hands, as instruments operate in close proximity to unprotected neural elements within the spinal canal. The risk is elevated in revision surgeries or severe stenosis with dural adhesions [3, 67].
Table 2.
Summary of common complications associated with ULIF
| Complication | Reported incidence | Key risk factors and clinical notes |
|---|---|---|
| Dural tear | Pooled rate: 3.3% [65]Cohort rates: 1.6% [38] | Risk factors include severe stenosis, dural adhesions, and the early learning curve. Most cases are managed conservatively |
| Symptomatic epidural hematoma | Reoperation rate: 1.9% [68]Pooled rate: 1.2% [65] | Risk factors: female sex, advanced age, anticoagulant use, high irrigation pressure. Asymptomatic hematoma rate on MRI can be as high as ~ 23% [68] |
| Neurological complications (palsy, dysesthesia) | Transient palsy/deficit: 1.8% [59]Permanent deficit: 0.6% [71]Dysesthesia/radicular pain: 4.1–4.7% [71] | Risks: excessive nerve root retraction during cage insertion, thermal injury. The overall incidence of transient nerve injury decreases significantly after the learning curve [60] |
| Surgical site infection | 0.08% [63] | Incidence is exceptionally low, widely attributed to continuous saline irrigation which reduces bacterial load |
| Cage-related complications (subsidence, migration) | Subsidence: 1.1% [38]Migration: 1.6% [60]Non-union: 1.9% [71] | Risk factors: osteoporosis, aggressive endplate preparation. Rates for cage subsidence (6.0%) and migration (2.6%) are higher during the early learning curve [60] |
| Reoperation (all-cause, 90 days) | Overall rate: 3.7%[60]Learning curve effect: 5.1% (early phase) vs. 1.4% (Late phase) [60] | Common causes: symptomatic hematoma, implant failure, inadequate decompression. The reoperation rate is highly correlated with surgeon experience |
| Incomplete decompression | 0.24% [65] | Incomplete decompression is a risk during the learning curve. However, Park et al. [60] showed similar rates in the early (4.3%) and late (4.2%) phases, suggesting it is a persistent technical challenge |
Incidence rates are compiled from systematic reviews and cohort studies and may vary based on surgeon experience
Postoperative spinal epidural hematoma (POSEH) is another significant concern, with a reported symptomatic incidence ranging from 1.1% to 8.4% [68, 69]. This risk is attributed to inadequate hemostasis on cancellous bone and the loss of the tamponade effect from fluid irrigation after surgery [70]. The 90-day reoperation rate for complications such as symptomatic hematoma or incomplete decompression reportedly decreased dramatically from 5.1% during the learning phase to 1.4% after proficiency was achieved, which highlights the critical impact of experience on patient safety [60]. While the rate of surgical site infection is exceptionally low (< 0.6%) due to continuous irrigation [15], the unique risks associated with the technique remain a point of debate and a barrier for many surgeons.
Debates on radiological outcomes
While clinical outcomes are comparable, the radiographic advantages of ULIF remain controversial [72]. A key goal of fusion is restoring segmental lordosis, but some studies suggest ULIF is less effective at this and at restoring disc height compared to other techniques such as oblique lumbar interbody fusion (OLIF) or even MIS–TLIF with hyperlordotic cages, primarily due to the posterior-only approach and limitations on cage placement angles [4, 46, 73].
Furthermore, the risk of cage subsidence is a persistent concern. Although meticulous endplate preparation under magnification is an advantage, the technical challenge of inserting a large cage through a small portal may necessitate the use of smaller cages, increasing contact stress and subsidence risk; innovations like large-footprint cages aim to mitigate this specific issue [52, 74]. Finally, while reported fusion rates are high, they derive largely from short- to mid-term follow-up, and long-term data are needed to confirm the durability of ULIF constructs [48].
Cost-effectiveness and clinically meaningful benefit
A crucial, often overlooked, barrier is cost-effectiveness. The initial capital investment for endoscopic towers, cameras, and specialized instruments is substantial. This investment, combined with longer operative times, may elevate the overall procedural cost above that of MIS–TLIF, potentially offsetting savings from shorter hospital stays [74, 75]. Furthermore, a critical question remains: do the observed benefits of ULIF—primarily reduced early postoperative pain and blood loss—constitute a clinically meaningful benefit sufficient to justify the steep learning curve, unique complication risks, and high costs? For many surgeons proficient in MIS–TLIF, the incremental advantages of ULIF may not be compelling enough to warrant a transition [15].
Limitations of current evidence and future directions
The current body of evidence on ULIF is constrained by its reliance on retrospective, single-center series, which are susceptible to selection bias. Consequently, a clear need exists for well-designed, multicenter randomized controlled trials (RCTs) to definitively compare the long-term efficacy and safety of ULIF against MIS–TLIF. Furthermore, most studies are limited to 1–2-year follow-up; data on long-term outcomes (> 5 years), such as rates of adjacent segment disease and the durability of fusion, are currently lacking [76].
Future research should prioritize the controversies highlighted in this review. Rigorous cost-effectiveness analyses are needed to clarify the economic impact of ULIF. Further investigation should also target granular radiological outcomes, particularly the ability to restore and maintain sagittal alignment compared to other MIS techniques. Finally, research into optimizing structured training programs is essential to mitigate the learning curve and ensure consistent, high-quality patient care.
Conclusion
ULIF has established itself as a technically feasible and effective minimally invasive technique. Current evidence indicates it can achieve clinical and radiological outcomes comparable to MIS–TLIF, offering advantages in reduced surgical trauma and accelerated early recovery. However, these benefits must be weighed against significant challenges, including a steep learning curve, a specific complication profile, and unresolved controversies regarding its radiological superiority and cost-effectiveness. For surgeons and institutions, adopting this technique requires a profound commitment to training and patient selection. High-quality RCTs with long-term follow-up are imperative to definitively solidify ULIF's role in the armamentarium of modern spine surgery and to guide its continued refinement.
Acknowledgements
Not applicable.
Abbreviations
- BE–EFLIF
Biportal endoscopic extraforaminal lumbar interbody fusion
- BE–TLIF
Biportal endoscopic transforaminal lumbar interbody fusion
- BESS
Biportal endoscopic spine surgery
- IED
Irrigation endoscopic discectomy
- LDH
Lumbar disc herniation
- LLIF
Lateral lumbar interbody fusion
- MIS
Minimally invasive surgery
- MIS–TLIF
Minimally invasive transforaminal lumbar interbody fusion
- OLIF
Oblique lumbar interbody fusion
- PLIF
Posterior lumbar interbody fusion
- POSEH
Postoperative spinal epidural hematoma
- RCTs
Randomized controlled trials
- TLIF
Transforaminal lumbar interbody fusion
- UBE
Unilateral biportal endoscopic
- UBE–TLIF
Unilateral biportal endoscopic transforaminal lumbar interbody fusion
- ULIF
Unilateral biportal endoscopic lumbar interbody fusion
Author contributions
LPH and LL conceived the study, conducted the literature search, interpretation, and manuscript writing; CSC assisted in drafting the manuscript; BJC helped verify the data; CJJ served as the corresponding author, reviewing and editing the methodology and manuscript. All authors contributed to the article and approved the submitted version.
Funding
This study was supported by the Natural Science Foundation of Shanxi Province, China (202403021221251).
Data availability
The data analyzed in this review are derived from publicly available studies, which can be accessed through the databases searched in our methodology, including PubMed, Web of Science, Embase, and the Cochrane Library.
Declarations
Ethics approval and consent to participate
This review uses data from published studies; therefore, ethical approval and individual consent to participate were not required. All included studies were conducted in accordance with ethical standards.
Consent for publication
Consent for publication was obtained from all subjects.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Ravindra VM, Senglaub SS, Rattani A, Dewan MC, Härtl R, Bisson E, Park KB, Shrime MG. Degenerative lumbar spine disease: estimating global incidence and worldwide volume. Global Spine J. 2018;8(8):784–94. 10.1177/2192568218770769 [DOI] [PMC free article] [PubMed]
- 2.Patel AA, Srivatsa S, Davison MA, Steinmetz MP. Posterior and transforaminal lumbar interbody fusion: recent advances in technique and technology. Neurosurg Clin N Am. 2025;36:11–20. 10.1016/j.nec.2024.08.001. [DOI] [PubMed] [Google Scholar]
- 3.Liu G, Liu W, Jin D, Yan P, Yang Z, Liu R. Clinical outcomes of unilateral biportal endoscopic lumbar interbody fusion (ULIF) compared with conventional posterior lumbar interbody fusion (PLIF). Spine J. 2023;23:271–80. 10.1016/j.spinee.2022.10.001. [DOI] [PubMed] [Google Scholar]
- 4.Park M-K, Park S-A, Son S-K, Park W-W, Choi S-H. Correction to: Clinical and radiological outcomes of unilateral biportal endoscopic lumbar interbody fusion (ULIF) compared with conventional posterior lumbar interbody fusion (PLIF): 1-year follow-up. Neurosurg Rev. 2019;42:763. 10.1007/s10143-019-01131-2. [DOI] [PubMed] [Google Scholar]
- 5.Li Y-S, Chen C-M, Hsu C-J, Yao Z-K. Complications of unilateral biportal endoscopic lumbar discectomy: a systematic review. World Neurosurg. 2022;168:359-368.e2. 10.1016/j.wneu.2022.10.038. [DOI] [PubMed] [Google Scholar]
- 6.Jagtiani P, Karabacak M, Margetis K. Comparative effectiveness of open versus minimally invasive transforaminal lumbar interbody fusion: an umbrella review of meta-analyses. Clin Spine Surg. 2024;37:E225–38. 10.1097/BSD.0000000000001561. [DOI] [PubMed] [Google Scholar]
- 7.Wei W-B, Dang S-J, Duan D-P, Zhao W, Wei L. Comparison of clinical efficacy and surgeon’s neck flexion time between unilateral biportal endoscopic lumbar fusion versus minimally invasive transforaminal lumbar fusion in the treatment of single-level lumbar degenerative diseases: a single center retrospective study. BMC Musculoskelet Disord. 2025;26:296. 10.1186/s12891-025-08406-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Ahn Y, Youn MS, Heo DH. Endoscopic transforaminal lumbar interbody fusion: a comprehensive review. Expert Rev Med Devices. 2019;16:373–80. 10.1080/17434440.2019.1610388. [DOI] [PubMed] [Google Scholar]
- 9.Wu PH, Kavishwar RA, Kim HS, W.B. Saunders. A narrative review of current and future of Unilateral Biportal Endoscopic (UBE) transforaminal lumbar interbody fusion. Semin Spine Surg. 2024;36:101084. 10.1016/j.semss.2024.101084. [Google Scholar]
- 10.So J-Y, Park J-Y, Korean Minimally Invasive Spine Surgery Society. Essential surgical techniques during unilateral biportal endoscopic spine surgery. J Minim Invasive Spine Surg Tech. 2023;8:186–97. [Google Scholar]
- 11.Kim J-E, Choi D-J. Biportal endoscopic transforaminal lumbar interbody fusion with arthroscopy. Clin Orthop Surg. 2018;10:248–52. 10.4055/cios.2018.10.2.248. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.He Y, Cheng Q, She J. Unilateral biportal endoscopic lumbar interbody fusion versus minimally invasive transforaminal lumbar interbody fusion for single-segment lumbar degenerative disease: A meta-analysis. BMC Musculoskelet Disord. 2024;25:938. 10.1186/s12891-024-08046-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Wang Y, Maimaiti A, Tuoheti A, Xiao Y, Zhang R, Kahaer A, et al. The method of portal making in lumbar unilateral biportal endoscopic surgery with different operative approaches according to the constant anatomical landmarks of the lumbar spine: a review of the literature. Glob Spine J. 2024;14:1838–61. 10.1177/21925682241230465. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Park J, Ahn D-K, Choi D-J. Treatment concept and technical considerations of biportal endoscopic spine surgery for lumbar spinal stenosis. Asian Spine J. 2024;18:301–23. 10.31616/asj.2023.0409. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Wang Q, Chang S, Dong J-F, Fang X, Chen Y, Zhuo C. Comparing the efficacy and complications of unilateral biportal endoscopic fusion versus minimally invasive fusion for lumbar degenerative diseases: a systematic review and mate-analysis. Eur Spine J. 2023;32:1345–57. 10.1007/s00586-023-07588-6. [DOI] [PubMed] [Google Scholar]
- 16.Heo DH, Hong YH, Lee DC, Chung HJ, Park CK. Technique of biportal endoscopic transforaminal lumbar interbody fusion. Neurospine. 2020;17:S129. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Gatam AR, Gatam L, Mahadhipta H, Ajiantoro A, Luthfi O, Aprilya D. Unilateral biportal endoscopic lumbar interbody fusion: a technical note and an outcome comparison with the conventional minimally invasive fusion. Orthop Res Rev. 2021;13:229–39. 10.2147/ORR.S336479. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Kang M-S, Chung H-J, Jung H-J, Park H-J. How i do it? Extraforaminal lumbar interbody fusion assisted with biportal endoscopic technique. Acta Neurochir (Wien). 2021;163:295–9. 10.1007/s00701-020-04435-1. [DOI] [PubMed] [Google Scholar]
- 19.Forst R, Hausmann B. Nucleoscopy ? a new examination technique. Arch Orthop Trauma Surg. 1983;101:219–21. 10.1007/BF00436774. [DOI] [PubMed] [Google Scholar]
- 20.Kambin P, Casey K, O’Brien E, Zhou L. Transforaminal arthroscopic decompression of lateral recess stenosis. J Neurosurg. 1996;84:462–7. 10.3171/jns.1996.84.3.0462. [DOI] [PubMed] [Google Scholar]
- 21.De Antoni DJ, Claro ML, Poehling GG, Hughes SS. Translaminar lumbar epidural endoscopy: anatomy, technique, and indications. Arthroscopy J Arthrosc Relat Surg. 1996;12:330–4. 10.1016/S0749-8063(96)90069-9. [DOI] [PubMed] [Google Scholar]
- 22.Soliman HM. Irrigation endoscopic discectomy: a novel percutaneous approach for lumbar disc prolapse. Eur Spine J. 2013;22:1037–44. 10.1007/s00586-013-2701-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Kang M-S, Heo DH, Kim H-B, Chung H-T. Biportal endoscopic technique for transforaminal lumbar interbody fusion: review of current research. Int J Spine Surg. 2021;15:S84-92. 10.14444/8167. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Heo DH, Son SK, Eum JH, Park CK. Fully endoscopic lumbar interbody fusion using a percutaneous unilateral biportal endoscopic technique: technical note and preliminary clinical results. Neurosurg Focus. 2017;43:E8. 10.3171/2017.5.FOCUS17146. [DOI] [PubMed] [Google Scholar]
- 25.Van Isseldyk F, Padilla-Lichtenberger F, Guiroy A, Asghar J, Quillo-Olvera J, Quillo-Reséndiz J, et al. Endoscopic treatment of lumbar degenerative disc disease: a narrative review of full-endoscopic and unilateral biportal endoscopic spine surgery. World Neurosurgery. 2024;188:e93-107. 10.1016/j.wneu.2024.05.047. [DOI] [PubMed] [Google Scholar]
- 26.Zhuang H-X, Guo S-J, Meng H, Lin J-S, Yang Y, Fei Q. Unilateral biportal endoscopic spine surgery for lumbar spinal stenosis: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci. 2023;27:4998–5012. 10.26355/eurrev_202306_32617. [DOI] [PubMed] [Google Scholar]
- 27.Liawrungrueang W, Lee H-J, Kim SB, Park S-M, Cholamjiak W, Park H-J. A systematic review of biportal endoscopic spinal surgery with interbody fusion. Asian Spine J. 2025;19:275–91. 10.31616/asj.2024.0425. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Heo DH, Kim HS, Whang YH, Lee DC, Lim K. History of endoscopic spine surgery: where did it all begin? Development of indications and techniques. Spine J. 2025;25:00351. 10.1016/j.spinee.2025.07.031. [DOI] [PubMed] [Google Scholar]
- 29.Heo DH, Eum JH, Jo JY, Chung H. Modified far lateral endoscopic transforaminal lumbar interbody fusion using a biportal endoscopic approach: technical report and preliminary results. Acta Neurochir. 2021;163:1205–9. 10.1007/s00701-021-04758-7. [DOI] [PubMed] [Google Scholar]
- 30.You K-H, Hyun J-T, Park S-M, Kang M-S, Cho SK, Park H-J. Comparison of clinical and radiologic outcomes between biportal endoscopic transforaminal lumbar interbody fusion and posterior lumbar interbody fusion. Sci Rep. 2024;14:29652. 10.1038/s41598-024-81402-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Bahir AW, Daxing W, Jiayu X, Bailian L, Shao G. Comparative efficacy and fusion outcomes of unilateral bi-portal endoscopic transforaminal lumbar interbody fusion versus minimally invasive transforaminal lumbar interbody fusion in treating single-segment degenerative lumbar spondylolisthesis with lumbar spinal stenosis: a two-year retrospective study. J Orthop Surg Res. 2024;19:835. 10.1186/s13018-024-05315-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Chan AK, Bydon M, Bisson EF, Glassman SD, Foley KT, Shaffrey CI, et al. Minimally invasive versus open transforaminal lumbar interbody fusion for grade I lumbar spondylolisthesis: 5-year follow-up from the prospective multicenter quality outcomes database registry. Neurosurg Focus. 2023;54:E2. 10.3171/2022.10.FOCUS22602. [DOI] [PubMed] [Google Scholar]
- 33.Shu P, Wang Z, Chen G. [Short-term effectiveness of unilateral biportal endoscopic transforaminal lumbar interbody fusion for meyerding degree I or II single-segment lumbar spondylolisthesis]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2022;36:1207–12. 10.7507/1002-1892.202205126. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.You X, Zhao B, Zhang T, Wang Y, Xu C, Yuan J, et al. Clinical efficacy of unilateral dual-channel endoscopic lumbar interbody fusion for lumbar spondylolisthesis with spinal scoliosis. Orthop Surg. 2024;16:1134–42. 10.1111/os.14046. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Luan H, Peng C, Liu K, Song X. Comparing the efficacy of unilateral biportal endoscopic transforaminal lumbar interbody fusion and minimally invasive transforaminal lumbar interbody fusion in lumbar degenerative diseases: a systematic review and meta-analysis. J Orthop Surg Res. 2023;18:888. 10.1186/s13018-023-04393-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Kim J-E, Yoo H-S, Choi D-J, Park EJ, Jee S-M. Comparison of minimal invasive versus biportal endoscopic transforaminal lumbar interbody fusion for single-level lumbar disease. Clin Spine Surg. 2021;34:E64-71. 10.1097/BSD.0000000000001024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Xie X, Zhang G, Liu N. Clinical effect of unilateral biportal endoscopy in the treatment of lumbar diseases: A systematic review and meta-analysis. Videosurg Miniinvas Techn Termed. 2022;17:61–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Guo W, Ye J, Li T, Yu Y, Fan X. Evaluation of the learning curve and complications in unilateral biportal endoscopic transforaminal lumbar interbody fusion: cumulative sum analysis and risk-adjusted cumulative sum analysis. J Orthop Surg Res. 2024;19:194. 10.1186/s13018-024-04674-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Yang H, Cheng F, Hai Y, Liu Y, Pan A. Unilateral biportal endoscopic lumbar interbody fusion enhanced the recovery of patients with the lumbar degenerative disease compared with the conventional posterior procedures: a systematic review and meta-analysis. Front Neurol. 2022;13:1089981. 10.3389/fneur.2022.1089981. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Gao X, Gao L, Chang Z, Hao D, Du J, Wu J, Zhao Z, Yang X, Hui H, He B, Yan L. Case series of unilateral biportal endoscopic-assisted transforaminal lumbar interbody fusion in the treatment of recurrent lumbar disc herniation. Am J Transl Res. 2022;14(4):2383. [PMC free article] [PubMed]
- 41.Lei F, Yanfang L, Shangxing W, Weihao Y, Wei L, Jing T. Spinal fusion versus repeat discectomy for recurrent lumbar disc herniation: a systematic review and meta-analysis. World Neurosurg. 2023;173:126-135.e5. 10.1016/j.wneu.2022.12.091. [DOI] [PubMed] [Google Scholar]
- 42.Peng Y-J, Fan Z-Y, Wang Q-L, Dai J, Zhang Q-Z-Y, Cao J-Y, et al. Comparison of the total and hidden blood loss in patients undergoing single-level open and unilateral biportal endoscopic transforaminal lumbar interbody fusion: a retrospective case control study. BMC Musculoskelet Disord. 2023;24:295. 10.1186/s12891-023-06393-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Dong R, Wu S, Zhong D, Zhao G, Liu Y, Wang Y, et al. Unilateral biportal endoscopic lumbar interbody fusion versus posterior lumbar interbody fusion for the treatment of bilateral lumbar spinal stenosis. Front Surg. 2025;12:1533458. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Hu Q, Xiao K, Nan J-N, Jhang S-W, Chen C-M, Lin G-X. Comparative evaluation of efficacy and complications between biportal endoscopic lumbar interbody fusion and minimally invasive transforaminal lumbar interbody fusion for lumbar degenerative diseases: a systematic review and meta-analysis. J Pain Res. 2025;18:2215–31. 10.2147/JPR.S472975. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Li X, Qu Y, Zhou L, Zhou Y, Peng B, Duo J. Meta-analysis of the clinical efficacy and safety of unilateral biportal endoscopic lumbar interbody fusion versus endoscopic lumbar interbody fusion for the treatment of lumbar degenerative diseases. World Neurosurg. 2025;195:123662. [DOI] [PubMed] [Google Scholar]
- 46.Yu Q, Hu X, Pan X, Kong X, Zhang J, Yu Y, et al. Early efficacy and safety of unilateral biportal endoscopic lumbar interbody fusion versus minimal invasive in the treatment of lumbar degenerative diseases. Clin Spine Surg. 2023. 10.1097/BSD.0000000000001470. [DOI] [PubMed] [Google Scholar]
- 47.Ma T, Tu X, Li J, Geng Y, Wu J, Chen S, et al. Comparative analysis of clinical efficacy of unilateral biportal endoscopic and open transforaminal lumbar interbody fusion in the treatment of lumbar degenerative. Front Surg. 2025;12:1487168. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Wu D, Shu T, Lu Q, Shen M. Prospective comparative study of unilateral biportal endoscopic transforaminal lumbar interbody fusion and endoscopic transforaminal lumbar interbody fusion for treatment of single-segment degenerative lumbar spinal stenosis with lumbar spondylolisthesis. Chin J Repar Reconstr Surg. 2024;38:521–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Zhao L, Zeng J, Xie T, Pu X, Lu Y. Advances in research on Cage subsidence following lumbar interbody fusion. Chin J Repar Reconstr Surg. 2021;35(8):1063–7. 10.7507/1002-1892.202104036 [DOI] [PMC free article] [PubMed]
- 50.Kim J-E, Kim H, Park EJ, Park DK. A comparison of 2 cage sizes in biportal endoscopic transforaminal lumbar interbody fusion. Clin Spine Surg. 2024. 10.1097/BSD.0000000000001633. [DOI] [PubMed] [Google Scholar]
- 51.Heo DH. Biportal endoscopic transforaminal lumbar interbody fusion using a large cage for degenerative spondylolisthesis with stenosis. Neurosurgical Focus: Video. 2024;10:V15. 10.3171/2024.1.FOCVID23231. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.You K-H, Hwang J-Y, Hong S-H, Kang M-S, Park S-M, Park H-J. Biportal endoscopic extraforaminal lumbar interbody fusion using a 3D-printed porous titanium cage with large footprints: technical note and preliminary results. Acta Neurochir. 2023;165:1435–43. 10.1007/s00701-023-05605-7. [DOI] [PubMed] [Google Scholar]
- 53.You K-H, Cho SK, Hwang J-Y, Cha S-H, Kang M-S, Park S-M, et al. Effect of cage material and size on fusion rate and subsidence following biportal endoscopic transforaminal lumbar interbody fusion. Neurospine. 2024;21:973–83. 10.14245/ns.2448244.122. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Kang TH, Cho M, Lee JH. Biportal endoscopic TLIF with an expandable cage: technical note and preliminary results in terms of segmental lordosis achievement and disc height elevation. Int J Spine Surg. 2024;18:571–81. 10.14444/8680. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Suvithayasiri S, Kim Y-J, Liu Y, Lee C, Vasant Khandge A, Kim J-S. Placement of 2 cages using navigation-guided biportal endoscopic transforaminal lumbar interbody fusion: illustrative case. J Cosmet Laser Ther. 2024;8:CASE23512. 10.3171/CASE23512. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Kang MG, Cho YS, Jang JY, Kang JH, Nguyen ND, Shin DA, et al. O-arm navigation-guided unilateral biportal endoscopic lumbar interbody fusion using a lateral lumbar interbody fusion cage. Asian Spine J. 2025. 10.31616/asj.2025.0015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Park H-J, Shin JI, You K-H, Yang JI, Kim N, Kim YH, et al. Biportal endoscopic transforaminal lumbar interbody fusion: how to improve fusion rate? Int J Spine Surg. 2024;18:582–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Wang N, Bei C, Wan J, Wang H. Learning curve analysis of unilateral biportal endoscopic lumbar interbody fusion. Chin J Repar Reconstr Surg. 2022;36:1229–33. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Kim J-E, Yoo H-S, Choi D-J, Hwang J-H, Park EJ, Chung S. Learning curve and clinical outcome of biportal endoscopic-assisted lumbar interbody fusion. Biomed Res Int. 2020;2020:8815432. 10.1155/2020/8815432. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Park S-M, Shin JI, Kim J-E, Kang M-S, You K-H, Kim JS, et al. Learning curve for biportal endoscopic transforaminal lumbar interbody fusion and 90-day postoperative complications during the learning phase: a multicenter retrospective cohort study. Eur Spine J. 2025. 10.1007/s00586-025-09235-8. [DOI] [PubMed] [Google Scholar]
- 61.Dong Y, Wang Y, Yu Y. Clinical efficacy of unilateral biportal endoscopic transforaminal lumbar interbody fusion. World Neurosurg. 2025;193:98–9. [DOI] [PubMed] [Google Scholar]
- 62.Chen K, Yang F-G, Luo Y-C, He R-J. Effect and complication among different kinds of spinal endoscopic surgery for lumbar disc herniation. Zhongguo Gu Shang. 2024;37:228–34. 10.12200/j.issn.1003-0034.20220860. [DOI] [PubMed] [Google Scholar]
- 63.Park DY, Upfill-Brown A, Curtin N, Hamad CD, Shah A, Kwon B, et al. Clinical outcomes and complications after biportal endoscopic spine surgery: a comprehensive systematic review and meta-analysis of 3673 cases. Eur Spine J. 2023;32:2637–46. 10.1007/s00586-023-07701-9. [DOI] [PubMed] [Google Scholar]
- 64.Ju CI, Lee SM. Complications and management of endoscopic spinal surgery. Neurospine. 2023;20:56–77. 10.14245/ns.2346226.113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Han H, Song Y, Li Y, Zhou H, Fu Y, Li J. Short-term clinical efficacy and safety of unilateral biportal endoscopic transforaminal lumbar interbody fusion versus minimally invasive transforaminal lumbar interbody fusion in the treatment of lumbar degenerative diseases: a systematic review and meta-analysis. J Orthop Surg Res. 2023;18:656. 10.1186/s13018-023-04138-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Huang X, Wang W, Chen G, Guan X, Zhou Y, Tang Y. Comparison of surgical invasiveness, hidden blood loss, and clinical outcome between unilateral biportal endoscopic and minimally invasive transforaminal lumbar interbody fusion for lumbar degenerative disease: a retrospective cohort study. BMC Musculoskelet Disord. 2023;24:274. 10.1186/s12891-023-06374-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Kim JY, Hong HJ, Kim HS, Heo DH, Choi SY, Kim KM, et al. Comparative analysis of uniportal and biportal endoscopic transforaminal lumbar interbody fusion in early learning stage: Technical considerations and radiological outcomes. J Minim Invasive Spine Surg Tech. 2024;9:S14–23. 10.21182/jmisst.2023.01032
- 68.Kim J-E, Choi D-J, Kim M-C, Park EJ. Risk factors of postoperative spinal epidural hematoma after biportal endoscopic spinal surgery. World Neurosurg. 2019;129:e324–9. 10.1016/j.wneu.2019.05.141. [DOI] [PubMed] [Google Scholar]
- 69.Ahn DK, Lee JS, Shin WS, Kim S, Jung J. Postoperative spinal epidural hematoma in a biportal endoscopic spine surgery. Medicine (Baltimore). 2021;100:e24685. 10.1097/MD.0000000000024685. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Wang H, Wang K, Lv B, Li W, Fan T, Zhao J, et al. Analysis of risk factors for perioperative hidden blood loss in unilateral biportal endoscopic spine surgery: a retrospective multicenter study. J Orthop Surg Res. 2021;16:559. 10.1186/s13018-021-02698-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Compagnone D, Mandelli F, Ponzo M, Langella F, Cecchinato R, Damilano M, et al. Complications in endoscopic spine surgery: a systematic review. Eur Spine J. 2024;33:401–8. 10.1007/s00586-023-07891-2. [DOI] [PubMed] [Google Scholar]
- 72.Lin G-X, Yao Z-K, Zhang X, Chen C-M, Rui G, Hu B-S. Evaluation of the outcomes of biportal endoscopic lumbar interbody fusion compared with conventional fusion operations: a systematic review and meta-analysis. World Neurosurg. 2022;160:55–66. [DOI] [PubMed] [Google Scholar]
- 73.Cao S, Fan B, Song X, Wang Y, Yin W. Oblique lateral interbody fusion (OLIF) compared with unilateral biportal endoscopic lumbar interbody fusion (ULIF) for degenerative lumbar spondylolisthesis: A 2-year follow-up study. J Orthop Surg Res. 2023;18:621. 10.1186/s13018-023-04111-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Yu Y, Wang Y, Xie Y, Xu J, Chen Y, Fan X. Comparison of mid-term effectiveness of unilateral biportal endoscopy-transforaminal lumbar interbody fusion with minimally invasive surgery-transforaminal lumbar interbody fusion assisted with three-dimensional microscope in treating lumbar spondylolisthesis. Zhongguo Xiu Fu Chong Jian Wai Ke Zazhi. 2023;37:52–8. 10.7507/1002-1892.202210017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Song X, Ren Z, Cao S, Zhou W, Hao Y. Clinical efficacy of bilateral decompression using biportal endoscopic versus minimally invasive transforaminal lumbar interbody fusion for the treatment of lumbar degenerative diseases. World Neurosurg. 2023;173:e371–7. [DOI] [PubMed] [Google Scholar]
- 76.Easthardt M, Park D, Zakko P, Kim JE. Biportal endoscopic transforaminal lumbar interbody fusion. JBJS Essent Surg Tech. 2025;15:e24.00005. 10.2106/JBJS.ST.24.00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The data analyzed in this review are derived from publicly available studies, which can be accessed through the databases searched in our methodology, including PubMed, Web of Science, Embase, and the Cochrane Library.


